Question

In: Accounting

On August 27, 2015, Celgene Corporation acquired all of the outstanding stock of Receptos, Inc., in...

On August 27, 2015, Celgene Corporation acquired all of the outstanding stock of Receptos, Inc., in exchange for $7.6 billion in cash. Referring to Celgene’s 2015 financial statements and its July 14, 2015, press release announcing the acquisition, answer the following questions regarding the Receptos acquisition.

Why did Celgene acquire Receptos?

What accounting method was used, and for what amount, to record the acquisition?

What amount did Celgene include in pre-combination service compensation in the total consideration transferred? What support is provided for this treatment in the Accounting Standards Codification (see ASC 805-30-30, paragraphs 9-13)?

What allocations did Celgene make to the assets acquired and liabilities assumed in the acquisition? Provide a calculation showing how Celgene determined the amount allocated to goodwill.

Describe the nature of the in-process research and development product rights acquired by Celgene in its acquisition of Receptos.

How will Celgene account for the in-process research and development product rights acquired in the Receptos combination?

Solutions

Expert Solution

Please go through the press release of Celgene corporation before taking the answers.

How will Celgene account for the in-process research and development product rights acquired in the Receptos combination? Post seperately

What amount did Celgene include in pre-combination service compensation in the total consideration transferred? What support is provided for this treatment in the Accounting Standards Codification (see ASC 805-30-30, paragraphs 9-13)? Post seperately

What accounting method was used, and for what amount, to record the acquisition?

Acquisition method comes into play when company acquires the other company and the acquirer company uses the GAAP standards.

Calegene accounted for its August 27 2015 acquisition of Receptos using the acquistion method .Accordingly Calgene recorded the acquisition of $7.6 billion.

Why did Celgene acquire Receptos?

The reason of acquisition can be understood from press release of the Celegene from 2015

The acquistion of Receptos significantly enhances Celegenes inflammation and Immunlogy (I & I) portfolio,further diverisfies the company revenue beginning in 2019 and beyond and builds upon Celegene's growing expertise in inflammatory bowel disease (IBD).The transaction adds Ozanimod a novel potential best in class ,oral,once daily selective sphingosine 1 -phosphate 1 and 5 receptor modulator (S1P) to celegen's deep and diverse pipeline of potential disease -altering medicines and investigational compounds.

What allocations did Celgene make to the assets acquired and liabilities assumed in the acquisition? Provide a calculation showing how Celgene determined the amount allocated to goodwill.

Goodwill can be calcuated as follows:

Cash                                                                                                $7311.20

Precombination service compensation        $314.90

Total fair Value of consideration transfered                                   $7626.20

Working Capital (Cash,A/R,A/P,Etc)               $479.20

Property plant and Equipment                        $5.00

In Process research and development         $6842.00

Current Deferred Taxes                                   $241.30

Other Non Current assets                               $7.90

Non Current deferred tax liabilities              - $2519.20

Total Fair Value of Net identifiable assets                                         $ 5056.20

Goodwill                                                                                            $2570.00

How will Celgene account for the in-process research and development product rights acquired in the Receptos combination?

The in process R & D Products that are acquired will be recorded as the intangible assets of the company.


Related Solutions

Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2017,...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2017, in exchange for $6,305,500 in cash. Allison intends to maintain Mathias as a wholly owned subsidiary. Both companies have December 31 fiscal year-ends. At the acquisition date, Mathias’s stockholders’ equity was $2,105,000 including retained earnings of $1,605,000. At the acquisition date, Allison prepared the following fair value allocation schedule for its newly acquired subsidiary: Consideration transferred $ 6,305,500 Mathias stockholders' equity 2,105,000 Excess fair...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020,...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020, in exchange for $6,039,000 in cash. Allison intends to maintain Mathias as a wholly owned subsidiary. Both companies have December 31 fiscal year-ends. At the acquisition date, Mathias’s stockholders’ equity was $2,040,000 including retained earnings of $1,540,000. At the acquisition date, Allison prepared the following fair-value allocation schedule for its newly acquired subsidiary: Consideration transferred $ 6,039,000 Mathias stockholders' equity 2,040,000 Excess fair over...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020,...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020, in exchange for $6,387,500 in cash. Allison intends to maintain Mathias as a wholly owned subsidiary. Both companies have December 31 fiscal year-ends. At the acquisition date, Mathias’s stockholders’ equity was $2,125,000 including retained earnings of $1,625,000. At the acquisition date, Allison prepared the following fair-value allocation schedule for its newly acquired subsidiary: Consideration transferred $ 6,387,500 Mathias stockholders' equity 2,125,000 Excess fair over...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020,...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020, in exchange for $6,387,500 in cash. Allison intends to maintain Mathias as a wholly owned subsidiary. Both companies have December 31 fiscal year-ends. At the acquisition date, Mathias’s stockholders’ equity was $2,125,000 including retained earnings of $1,625,000. At the acquisition date, Allison prepared the following fair-value allocation schedule for its newly acquired subsidiary: Consideration transferred $ 6,387,500 Mathias stockholders' equity 2,125,000 Excess fair over...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2017,...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2017, in exchange for $6,162,000 in cash. Allison intends to maintain Mathias as a wholly owned subsidiary. Both companies have December 31 fiscal year-ends. At the acquisition date, Mathias’s stockholders’ equity was $2,070,000 including retained earnings of $1,570,000. At the acquisition date, Allison prepared the following fair value allocation schedule for its newly acquired subsidiary: Consideration transferred $ 6,162,000 Mathias stockholders' equity 2,070,000 Excess fair...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020,...
Allison Corporation acquired all of the outstanding voting stock of Mathias, Inc., on January 1, 2020, in exchange for $5,957,000 in cash. Allison intends to maintain Mathias as a wholly owned subsidiary. Both companies have December 31 fiscal year-ends. At the acquisition date, Mathias’s stockholders’ equity was $2,020,000 including retained earnings of $1,520,000. At the acquisition date, Allison prepared the following fair-value allocation schedule for its newly acquired subsidiary: Consideration transferred $ 5,957,000 Mathias stockholders' equity 2,020,000 Excess fair over...
On May 28, 2021, Pesky Corporation acquired all of the outstanding common stock of Harman, Inc.,...
On May 28, 2021, Pesky Corporation acquired all of the outstanding common stock of Harman, Inc., for $510 million. The fair value of Harman's identifiable tangible and intangible assets totaled $575 million, and the fair value of liabilities assumed by Pesky was $149 million. Pesky performed a goodwill impairment test at the end of its fiscal year ended December 31, 2021. Management has provided the following information: Fair value of Harman, Inc. $ 490 million Fair value of Harman's net...
PACE Corporation acquired all of the outstanding common stock of LINK Inc. on January 1, 2016...
PACE Corporation acquired all of the outstanding common stock of LINK Inc. on January 1, 2016 in exchange for for 20,000 shares of PACE Corp's $10 par value Common Stock that was trading at $50 a share on that date. LINK Inc.'s accounting records showed a net book value on that date of $600,000: Common Stock 200,000 Retained Earnings 400,000 Total Equity 600,000 Equipment on the LINK's books with a 5-year life was undervalued by $150,000. Any additional excess fair...
Print Corporation acquired all outstanding $10 par value voting common stock of Size Inc. on January...
Print Corporation acquired all outstanding $10 par value voting common stock of Size Inc. on January 1, 20X9, in exchange for 25,000 shares of its $20 par value voting common stock. On December 31, 20X8, Print’s common stock had a closing market price of $30 per share on a national stock exchange. The acquisition was appropriately accounted for under the acquisition method. Both companies continued to operate as separate business entities maintaining separate accounting records with years ending December 31....
On August 1, 2012, all of the outstanding stock of Bridge Corporation (a calendar year taxpayer)...
On August 1, 2012, all of the outstanding stock of Bridge Corporation (a calendar year taxpayer) was purchased from an unrelated party for cash by Infrastructure Corporation. On July 1, 2015, Bridge adopted a resolution providing for a plan to completely liquidate. The plan of complete liquidation provided that Bridge would be liquidated upon payment of its indebtedness to a large, publicly held lender, but in any event not later than March, 2018. Bridge’s loan agreement had been entered into...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT